These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10982162)
1. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Fall PM; Kennedy D; Smith JA; Seibel MJ; Raisz LG Osteoporos Int; 2000; 11(6):481-5. PubMed ID: 10982162 [TBL] [Abstract][Full Text] [Related]
2. Markers of bone resorption--measurement in serum, plasma or urine? Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175 [TBL] [Abstract][Full Text] [Related]
3. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652 [TBL] [Abstract][Full Text] [Related]
4. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528 [TBL] [Abstract][Full Text] [Related]
5. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover. Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625 [TBL] [Abstract][Full Text] [Related]
6. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study. Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806 [TBL] [Abstract][Full Text] [Related]
7. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Shaarawy M; Zaki S; Sheiba M; El-Minawi AM Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333 [TBL] [Abstract][Full Text] [Related]
8. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption. Taga M; Uemura T; Minaguchi H J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756 [TBL] [Abstract][Full Text] [Related]
10. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218 [TBL] [Abstract][Full Text] [Related]
11. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. Shaarawy M; Hasan M Scand J Clin Lab Invest; 2001; 61(7):513-21. PubMed ID: 11763409 [TBL] [Abstract][Full Text] [Related]
12. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. Garnero P; Delmas PD Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032 [TBL] [Abstract][Full Text] [Related]
13. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464 [TBL] [Abstract][Full Text] [Related]
14. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis. Kawana K; Takahashi M; Hoshino H; Kushida K Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280 [TBL] [Abstract][Full Text] [Related]
15. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy. Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391 [TBL] [Abstract][Full Text] [Related]
16. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [TBL] [Abstract][Full Text] [Related]
17. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288 [TBL] [Abstract][Full Text] [Related]
18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729 [TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Sone T; Miyake M; Takeda N; Fukunaga M Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404 [TBL] [Abstract][Full Text] [Related]
20. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss]. Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]